Healthcare >> Analyst Interviews >> August 19, 2014
Clinical Advancements and Drug Launches in Therapeutics Fuel Investor Enthusiasm
Brian Klein, M.D. joined Stifel, Nicolaus & Co., Inc. in 2012 and is a Vice President in the health care sector, covering biotechnology. Before joining Stifel, Nicolaus & Co., Inc., Dr. Klein was an Analyst with Lazard Capital Markets, and a Medical Resident at St. Luke's-Roosevelt Hospital. He remains board-certified in internal medicine. Dr. Klein is a graduate of Yale University, earned an M.S. in physiology and biophysics from Georgetown University, and an M.D. from New York Medical College. Profile
TWST: How would you characterize what's going on in the biotech space at this point? Is it M&A activity or is it really business that's driving things along?